LUNG CANCER, BILIARY TRACT CANCER

Clinical trials for LUNG CANCER, BILIARY TRACT CANCER explained in plain language.

Never miss a new study

Get alerted when new LUNG CANCER, BILIARY TRACT CANCER trials appear

Sign up with your email to follow new studies for LUNG CANCER, BILIARY TRACT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Cancer Drug's Real-World performance tracked in major korean study

Disease control Completed

This study monitored how well the cancer drug durvalumab (Imfinzi) worked and how safe it was for patients in everyday medical practice in Korea. It included 712 people with lung cancer or biliary tract cancer who were eligible to receive the drug as per its approved label. The m…

Matched conditions: LUNG CANCER, BILIARY TRACT CANCER

Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 18, 2026 14:40 UTC

LUNG CANCER, BILIARY TRACT CANCER

Get alerted when new LUNG CANCER, BILIARY TRACT CANCER trials appear

Cancer Drug's Real-World performance tracked in major korean study